Molecule intelOpportunity: ModerateEssential

Clomipramine

22 brands · 12 companies · product forms

ATC: N06AA04

Opportunity snapshot

Launch attractiveness
49
Market saturation
32
Price room
100
Regulatory risk
0
22
brands
12
companies
Rs 330.45
median price
21
price points
10.49x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 23%

Price room

Across observed sources and strengths
CheapestRs 76
MedianRs 330.45
Most expensiveRs 797.07
Spread10.49×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 10.49x across 21 trusted points (Rs 76.0-797.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Clomipramine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(68) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

12 canonical companies and 22 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 10.49x across 21 trusted points (Rs 76.0-797.07). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.